Feasibility, Safety, and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study-Reference-Cited by-同舟云学术

Feasibility, Safety, and Efficacy of the Combination of D-Serine and Computerized Cognitive Retraining in Schizophrenia: An International Collaborative Pilot Study

Published:2012-10-24 Issue:3 Volume:38 Page:492-503
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

D'Souza Deepak C,Radhakrishnan Rajiv,Perry Edward,Bhakta Savita,Singh Nagendra M,Yadav Richa,Abi-Saab Danielle,Pittman Brian,Chaturvedi Santosh K,Sharma Mahendra P,Bell Morris,Andrade Chittaranjan

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp2012208.pdf

Reference49 articles.

1. Addington D, Addington J, Schissel B (1990). A depression rating scale for schizophrenics. Schizophr Res 3: 247–251.

2. Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS (1994). Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 116: 143–151.

3. Barnes TR (1989). A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672–676.

4. Bell MD, Fiszdon JM, Bryson G (2009). Attention training in schizophrenia: differing responses to similar tasks. J Psychiatr Res 43: 490–496.

5. Bradley SR, Lameh J, Ohrmund L, Son T, Bajpai A, Nguyen D et al (2010). AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model. Neuropharmacology 58: 365–373.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finding the right dose: NMDAR modulating treatments for cognitive and plasticity deficits in schizophrenia and the role of pharmacodynamic target engagement;Biological Psychiatry;2024-08

2. Cross species review of the physiological role of d-serine in translationally relevant behaviors;Amino Acids;2023-10-13

3. Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine;Biological Psychiatry;2023-07

4. Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia;Schizophrenia Research;2023-06

5. Efficacy of Cognitive Training Program Given to Patients with Schizophrenia Using Computer Tablets: a Preliminary Study;International Journal of Cognitive Therapy;2023-01-28